Jersey Shore NJ
Moleculin Announces New Data Shows Reversal of Tumor Activity in Animal Models
HOUSTON, Dec. 19, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of dru…
